Ando K - Search Results

1

The hepatic niche leads to aggressive natural killer cell leukemia proliferation through the transferrin-transferrin receptor 1 axis.

Kameda K, Yanagiya R, Miyatake Y, Carreras J, Higuchi H, Murayama H, Ishida T, Ito A, Iida S, Fukuhara N, Harigae H, Fujioka Y, Takahashi N, Wada H, Ishida F, Nakazawa H, Ishihara R, Murakami Y, Tagawa H, Matsuura T, Nakagawa S, Iwabuchi S, Hashimoto S, Imadome KI, Nakamura N, Ishizawa K, Kanda Y, Ando K, Kotani A. Kameda K, et al. Among authors: ando k. Blood. 2023 Jul 27;142(4):352-364. doi: 10.1182/blood.2022018597. Blood. 2023. PMID: 37146246

2

Low-intensity pulsed ultrasound stimulates cell proliferation and proteoglycan production in rabbit intervertebral disc cells cultured in alginate.

Iwashina T, Mochida J, Miyazaki T, Watanabe T, Iwabuchi S, Ando K, Hotta T, Sakai D. Iwashina T, et al. Among authors: ando k. Biomaterials. 2006 Jan;27(3):354-61. doi: 10.1016/j.biomaterials.2005.06.031. Epub 2005 Aug 15. Biomaterials. 2006. PMID: 16099036

3

An atypical form of Asian variant of intravascular large B-cell lymphoma presenting with myelopathy alone for 4 months prior to pancytopenia.

Takizawa S, Shirasugi Y, Nakamura N, Nakagawa S, Tsuchiya T, Ando K, Takagi S. Takizawa S, et al. Among authors: ando k. Intern Med. 2007;46(22):1879-80. doi: 10.2169/internalmedicine.46.0327. Epub 2007 Nov 16. Intern Med. 2007. PMID: 18025772 Free article. No abstract available.

4

Characterization of de novo diffuse large B-cell lymphoma with a translocation of c-myc and immunoglobulin genes.

Kikuchi A, Nakamura N, Kuze T, Sasaki Y, Abe M, Ohno H, Akasaka T, Nakamura S, Ohshima K, Ando K. Kikuchi A, et al. Among authors: ando k. Leuk Res. 2008 Aug;32(8):1176-82. doi: 10.1016/j.leukres.2007.10.006. Leuk Res. 2008. PMID: 18460403

5

[Granulocytic sarcoma of the prostate presenting with urinary obstruction which progressed to acute myeloid leukemia].

Tsuboi K, Kawada H, Suzuki R, Murayama H, Ohmachi K, Nakamura N, Ogawa Y, Ando K. Tsuboi K, et al. Among authors: ando k. Rinsho Ketsueki. 2008 Nov;49(11):1562-5. Rinsho Ketsueki. 2008. PMID: 19047789 Japanese.

6

Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia.

Sakamaki H, Ishizawa KI, Taniwaki M, Fujisawa S, Morishima Y, Tobinai K, Okada M, Ando K, Usui N, Miyawaki S, Utsunomiya A, Uoshima N, Nagai T, Naoe T, Motoji T, Jinnai I, Tanimoto M, Miyazaki Y, Ohnishi K, Iida S, Okamoto S, Seriu T, Ohno R. Sakamaki H, et al. Among authors: ando k. Int J Hematol. 2009 Apr;89(3):332-341. doi: 10.1007/s12185-009-0260-2. Epub 2009 Mar 5. Int J Hematol. 2009. PMID: 19263190 Clinical Trial.

7

Three cases of bortezomib-resistant multiple myeloma with extramedullary masses.

Moriuchi M, Ohmachi K, Kojima M, Tsuboi K, Ogawa Y, Nakamura N, Ando K. Moriuchi M, et al. Among authors: ando k. Tokai J Exp Clin Med. 2010 Apr 20;35(1):17-20. Tokai J Exp Clin Med. 2010. PMID: 21319020 Free article.

8

Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia: a retrospective safety analysis.

Kobayashi Y, Sakamaki H, Fujisawa S, Ando K, Yamamoto K, Okada M, Ishizawa K, Nagai T, Miyawaki S, Motoji T, Usui N, Iida S, Taniwaki M, Uoshima N, Seriu T, Ohno R. Kobayashi Y, et al. Among authors: ando k. Int J Hematol. 2011 Jun;93(6):745-749. doi: 10.1007/s12185-011-0864-1. Epub 2011 May 20. Int J Hematol. 2011. PMID: 21594763

9

Accumulation of oxidative DNA damage restricts the self-renewal capacity of human hematopoietic stem cells.

Yahata T, Takanashi T, Muguruma Y, Ibrahim AA, Matsuzawa H, Uno T, Sheng Y, Onizuka M, Ito M, Kato S, Ando K. Yahata T, et al. Among authors: ando k. Blood. 2011 Sep 15;118(11):2941-50. doi: 10.1182/blood-2011-01-330050. Epub 2011 Jul 6. Blood. 2011. PMID: 21734240 Free article.

10

Imatinib mesylate directly impairs class switch recombination through down-regulation of AID: its potential efficacy as an AID suppressor.

Kawamata T, Lu J, Sato T, Tanaka M, Nagaoka H, Agata Y, Toyoshima T, Yokoyama K, Oyaizu N, Nakamura N, Ando K, Tojo A, Kotani A. Kawamata T, et al. Among authors: ando k. Blood. 2012 Mar 29;119(13):3123-7. doi: 10.1182/blood-2011-01-327932. Epub 2012 Feb 14. Blood. 2012. PMID: 22337716 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,692 results

Search Page